Archives of Psychiatric Nursing
Volume 25, Issue 1 , Pages 24-35 , February 2011

Symptom Management of Affective and Cognitive Disturbance With a Group of Cancer Survivors

References 

  1. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology. 2002;15(2):485–493
  2. Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE. Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the International Neuropsychological Society. 2003;9(7):967–982
  3. Badger T, Segrin C, Dorros SM, Meek P, Lopez AM. Depression and anxiety in women with breast cancer and their partners. Nursing Research. 2007;56(1):44–53
  4. Bandura A. Self-efficacy: The exercise of control. New York: W. H. Freeman and Company; 1997;
  5. Beer TM, Bland LB, Bussiere JR, Neiss MB, Wersinger EM, Garzotto M, et al. Testosterone loss and estradiol administration modify memory in men. Journal Urology. 2006;175(1):130–135
  6. Benedict RHB. Brief Visuospatial Memory Test—Revised: Professional manual. Odessa, FL: Psychological Assessment Resources, Inc; 1997;
  7. Benedict RHB, Dobraski M, Goldstein MZ. A preliminary study of the association between changes in mood and in a mixed geriatric sample. Journal of Gerontology: Psychological Sciences. 1999;54B(2):P94–P99
  8. Berger AM, Walker SN. An explanatory model of fatigue in women receiving adjuvant breast cancer chemotherapy. Nursing Research. 2001;50(1):42–52
  9. Berry JM, West RL, Dennehey DM. Reliability and validity of the Memory Self-Efficacy Questionnaire. Developmental Psychology. 1989;25(5):701–713
  10. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology. 2000;18(4):743–753
  11. Brandt J. The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. The Clinical Neuropsychologist. 1991;5:125–142
  12. Caplette-Gingras A, Savard J. Depression in women with metastatic breast cancer: a review of the literature. Palliative Support Care. 2008;6(4):377–387
  13. Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology. 2004;26(7):955–969
  14. Cockburn J, Smith PT. The Rivermead Behavioural Memory Test. Supplement 3: Elderly people. Bury St. Edmunds, Suffolk: Thames Valley Test Company; 1989;
  15. Devolder PA, Pressley M. Causal attributions and strategy use in relation to memory performance differences in younger and older adults. Applied Cognitive Psychology. 1992;6:629–642
  16. Dixon RA, Hultsch DF, Hertzog C. The Metamemory in Adulthood (MIA) questionnaire. Psychopharmacology Bulletin. 1988;24(4):671–688
  17. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer. 2004;104(11):2499–2507
  18. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition. 2005;59(1):60–70
  19. Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, et al. Major depression after breast cancer: a review of epidemiology and treatment. General Hospital Psychiatry. 2008;30(2):112–126
  20. Ferguson RJ, Ahles TA. Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Current Neurology and Neuroscience Reports. 2003;3(3):215–222
  21. Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CF, Cole BF, et al. Cognitive–Behavioral management of chemotherapy-related cognitive change. Psychooncology. 2007;16(8):772–777
  22. Fogler J, Stern L. Teaching memory improvement to adults. (Rev ed). Baltimore, MD: John Hopkins University Press.; 1994;
  23. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;2:189–198
  24. Gonzalez EC, Ferrante JM, Van Durme DJ, Pal N, Roetzheim RG. Comorbid illness and the early detection of cancer. Southern Medical Journal. 2001;94(9):913–920
  25. Greiner PA, Snowdon DA, Schmitt FA. The loss of independence in activities of daily living: The role of low normal cognitive function in elderly nuns. American Journal Public Health. 1996;86(1):62–66
  26. Intons-Peterson MJ, Fournier J. External and internal memory aids: When and how often do we use them. Journal of Experimental Psychology General. 1986;115(3):267–280
  27. Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J. A meta analysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer. 2005;104(10):2222–2233
  28. Lawton MP. Scales to measure competence in everyday activities. Psychopharmacology Bulletin. 1988;24(4):609–614
  29. Liu K, Wall S, Wissoker D. Disability and Medicare costs of elderly persons. The Milbank Quarterly. 1997;75(4):461–493
  30. Lowenstein D, Amigo E, Duara R, Guterman A, Hurwitz D, Berkowitz N, et al. A new scale for the assessment of functional status in Alzheimer's disease and related disorders. Journal of Gerontology: Psychological Sciences. 1989;44(4):P114–P121
  31. Lowenstein DA, Ardila A, Rosselli M, Hayden S, Duara R, Berkowitz N, et al. A comparative analysis of functional status among Spanish- and English-speaking patients with dementia. Journal of Gerontology: Psychological Sciences. 1992;47(6):P389–P394
  32. Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients—Evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer. 2005;12(4):279–287
  33. McAllister TW, Ahles TA, Saykin AJ, Ferguson RJ, McDonald BC, Lewis LD, et al. Cognitive effects of cytotoxic cancer chemotherapy: Predisposing risk factors and potential treatments. Current Psychiatry Reports. 2004;6(5):364–371
  34. McDougall GJ. Increasing memory self-efficacy and memory strategy use in Hispanic elders. Clinical Gerontologist. 1998;19(2):57–76
  35. McDougall GJ. Cognitive interventions among older adults. Annual Review of Nursing Research. 1999;17:219–240
  36. McDougall GJ. Memory improvement in assisted living elders. Issues in Mental Health Nursing. 2000;21(2):217–233
  37. McDougall GJ. Memory improvement program for elderly cancer survivors. Geriatric Nursing. 2001;22(4):185–190
  38. McDougall GJ. Memory improvement in octogenarians. Applied Nursing Research. 2002;15(1):2–10
  39. McDougall GJ. A Framework for cognitive interventions targeting everyday memory performance and memory self-efficacy. Family & Community Health (Supplement 1): Advancing Healthy Aging. 2009;32(1S):S15–S26
  40. McDougall GJ, Becker H, Acee TW, Vaughan PW, Pituch K, Delville C. Health-training intervention for community-dwelling elderly in the SeniorWISE Study. Archives Psychiatric Nursing. 2010;24(2):125–136
  41. McDougall GJ, Becker H, Arheart KL. Older adults in the SeniorWISE study at-risk for mild cognitive impairment. Archives of Psychiatric Nursing. 2006;20(3):126–134
  42. National Institutes of Health . Life after cancer treatment (No. 04-2424). Bethesda, MD: U. S. Governement Printing Office; 2004;
  43. National Cancer Institute . Lifetime risk (percent) of being diagnosed with cancer by site, race, and sex (DevCan software, version 6.0). Rockville, MD: Author; 2005;Retrieved from http://srab.cancer.gov/devcan/
  44. Office of Cancer Survivorship . Estimated U.S. Cancer Prevalence. National Cancer Institute; 2010;http://cancercontrol.cancer.gov/ocs/prevalence/prevalence.html#survivor
  45. Perkins EA, Small BJ, Balducci L, Extermann M, Robb C, Haley WE. Individual differences in well-being in older breast cancer survivors. Critical Review Oncology and Hematology. 2007;62(1):74–83
  46. Radloff LS, Teri L. Use of the center for epidemiological studies-depression scale with older adults. Clinical Gerontologist. 1986;5(1/2):119–136
  47. Segar ML, Katch VL, Roth RS, Garcia AW, Portner TL, Glickman SG, et al. The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncology Nursing Forum. 1998;25(1):107–113
  48. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory (Self-Evaluation Questionnaire). Palo Alto, CA: Consulting Psychologists Press; 1970;
  49. Tannock IF, Ahles TA, Ganz PA, van Dam FS. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. Journal of Clinical Oncology. 2004;22(11):2233–2239
  50. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer. 2004;100(11):2292–2299
  51. Wilson B, Cockburn J, Baddeley A, Hiorns R. The development and validation of a test battery for detecting and monitoring everyday memory problems. Journal of Clinical and Experimental Neuropsychology. 1989;11(6):855–870

 Sponsor's role: None. Trial Registration ClinicalTrials.gov NCT00094731 http://www.clinicaltrials.gov/ct/show/NCT00094731.

PII: S0883-9417(10)00057-9

doi: 10.1016/j.apnu.2010.05.004

Archives of Psychiatric Nursing
Volume 25, Issue 1 , Pages 24-35 , February 2011

Article Tools

* Image Usage & Resolution